KR20090027295A - Cosmetic composition for skin moisturizing containing thyme extract - Google Patents
Cosmetic composition for skin moisturizing containing thyme extract Download PDFInfo
- Publication number
- KR20090027295A KR20090027295A KR1020070092404A KR20070092404A KR20090027295A KR 20090027295 A KR20090027295 A KR 20090027295A KR 1020070092404 A KR1020070092404 A KR 1020070092404A KR 20070092404 A KR20070092404 A KR 20070092404A KR 20090027295 A KR20090027295 A KR 20090027295A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- thyme extract
- moisturizing
- lotion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 50
- 241000246358 Thymus Species 0.000 title claims abstract description 45
- 235000007303 Thymus vulgaris Nutrition 0.000 title claims abstract description 45
- 239000001585 thymus vulgaris Substances 0.000 title claims abstract description 45
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 27
- 210000003491 skin Anatomy 0.000 claims abstract description 64
- 230000037303 wrinkles Effects 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000001704 evaporation Methods 0.000 claims abstract description 10
- 230000008020 evaporation Effects 0.000 claims abstract description 10
- 210000002615 epidermis Anatomy 0.000 claims abstract description 9
- 239000006210 lotion Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000006071 cream Substances 0.000 claims description 13
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 230000035764 nutrition Effects 0.000 claims description 8
- 210000000434 stratum corneum Anatomy 0.000 claims description 8
- -1 body cleanser Substances 0.000 claims description 7
- 239000000686 essence Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000008269 hand cream Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 230000005808 skin problem Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 239000005445 natural material Substances 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000007012 clinical effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001120 cytoprotective effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000329467 Thymus quinquecostatus Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 백리향 추출물을 함유하는 피부보습 증진 효과가 있는 화장료 조성물에 관한 것으로, 백리향 추출물이 피부보습력을 상승시킬 뿐만 아니라 표피의 수분증발 억제 효과를 갖는다. 기존에 사용되고 있는 화학물질로 이루어진 보습성분은 독성, 피부알러지, 피부 트러블 등과 같은 부작용을 일으킬 수 있는 단점이 있는데 반하여, 본 발명에서 사용되는 백리향 추출물은 천연물질을 사용함으로써 독성, 피부알러지, 피부 트러블 등의 부작용을 일으키지 않고, 피부 보습력을 증진시킬 뿐만 아니라 피부의 주름개선에도 효과가 있다.The present invention relates to a cosmetic composition having a skin moisturizing enhancing effect containing a thyme extract, the thyme extract not only increases the skin moisturizing power, but also has an effect of inhibiting water evaporation of the epidermis. Moisturizing ingredients made of conventional chemicals have the disadvantage that can cause side effects such as toxicity, skin allergies, skin problems, etc., thyme extract used in the present invention is toxic, skin allergy, skin problems by using natural substances It does not cause side effects, etc., and improves skin moisturizing power, and is effective in improving wrinkles of the skin.
Description
본 발명은 백리향(Thymus quinquecostatus) 추출물을 함유하는 피부 보습용 화장료 조성물에 관한 것으로, 백리향 추출물이 피부보습력을 상승시킬 뿐만 아니라 표피의 수분증발 억제 효과를 갖고, 기존에 사용되고 있는 화학물질로 이루어진 보습성분은 독성, 피부알러지, 피부 트러블 등과 같은 부작용을 일으킬 수 있는 단점이 있는데 반하여, 본 발명에서 사용되는 백리향 추출물은 천연물질을 사용함으로써 독성, 피부알러지, 피부 트러블 등의 부작용을 일으키지 않고, 피부 보습력을 증진시킬 뿐만 아니라 피부의 주름개선에도 효과가 있다.The present invention is Thymus ( Thymus) quinquecostatus ) relates to a skin moisturizing cosmetic composition containing an extract, the thyme extract not only increases the skin moisturizing power, but also has the effect of inhibiting water evaporation of the epidermis. While there are disadvantages that may cause side effects such as skin troubles, the thyme extract used in the present invention does not cause side effects such as toxicity, skin allergies, and skin troubles by using natural substances, and not only improves skin moisturizing ability but also of skin. It is also effective for wrinkle improvement.
피부는 다양한 외부 요인들로부터 물리적, 화학적 상해를 직접 받는 부위인 동시에 또한 이들의 기능적, 구조적 손상을 치유할 수 있는 능력을 가진 우리가 살아가는데 없어서는 안될 조직이다. 그러나, 우리의 피부는 각종 오염물질과 스트레스 등으로 인해 손상을 입게 되는데, 이와 같은 손상으로 피부의 세포 증식이 제대로 이루어지지 않게 되면 피부는 더욱 더 큰 손상을 입게 되고 빠르게 피부 탄력이 저하되고, 주름이 생성되게 된다. 피부가 노화되면 피부 탄력에 중요한 역할을 하고 있는 매트릭스(Matrix)안의 콜라겐(collagen), 뮤코다당류(mucopolysaccharide), 히알루론산(hyaluronic acid)의 양이 줄어들고, 불용성 콜라겐의 양이 증가한다. 이렇게 되면 진피는 피부의 수분을 유지하기 어렵게 되고 피부는 거칠게 된다. 나아가 피지샘과 땀샘의 기능도 감소하여 피지와 땀의 양이 점차로 줄어들게 된다. 이로 인해 피지막(sebaceous membrane)은 적당히 생성되지 못하고 피부 수화에 대한 보호력을 잃게 되어 결국 피부는 건조하게 되고 투명성(translucency)을 잃게 되어 피부 단백질의 탄력이 감소되고 주름이 생성된다. Skin is an indispensable tissue in our lives, a site that is directly affected by physical and chemical injuries from various external factors, as well as having the ability to cure their functional and structural damage. However, our skin is damaged by various contaminants and stress. If the cell proliferation is not properly performed by such damage, the skin is damaged more and more quickly, the elasticity of the skin decreases quickly, and wrinkles Will be generated. As the skin ages, the amount of collagen, mucopolysaccharide, and hyaluronic acid in the matrix, which play an important role in skin elasticity, decreases, and the amount of insoluble collagen increases. This makes it difficult for the dermis to keep the skin hydrated and the skin rough. In addition, the function of the sebaceous glands and sweat glands is also reduced, and the amount of sebum and sweat is gradually reduced. As a result, the sebaceous membrane is not properly formed and the protection against skin hydration is lost. As a result, the skin becomes dry and loses its translucency, thereby reducing the elasticity of skin proteins and producing wrinkles.
한편, 피부의 보습 작용도 기능을 다하지 못하면 피부 탄력 저하의 원인이 된다. 즉, 피부의 보습력 상실은 피부노화의 중요한 요인이 되고 있다. 피부의 수분균형은 표피(epidermis)에 의해 조절된다. 표피의 각질층은 죽은 세포들이 쌓여 있는 것이지만 피부의 수분유지를 위해서 매우 중요한 역할을 한다. 사람의 생체는 생명체 유지에 중요한 역할을 하는 물로 대부분 구성되어 있다. 정상피부에서의 수분은 체내에 70%, 각질층에 20%가 함유되어 있어 피부의 탄력성 및 유연성을 지탱해 준다. 각질층의 수분이 10% 이하일 경우, 피부는 건성화되고 피부 트러블의 원인이 된다고 알려져 있다. 규칙적인 각질화(keratinization)로 생성된 각질층 안의 수분의 양은 항상 10~20%를 유지한다.On the other hand, if the skin's moisturizing action also fails to function can cause a decrease in skin elasticity. In other words, the loss of the skin's moisturizing power has become an important factor of skin aging. Moisture balance in the skin is controlled by the epidermis. The stratum corneum of the epidermis is the accumulation of dead cells, but plays a very important role in maintaining skin moisture. Human living bodies are mostly composed of water, which plays an important role in maintaining life. Moisture in normal skin is 70% in the body and 20% in the stratum corneum to support the elasticity and flexibility of the skin. If the moisture in the stratum corneum is less than 10%, the skin is known to dry out and cause skin problems. The amount of moisture in the stratum corneum produced by regular keratinization is always 10-20%.
현재, 주로 사용되고 있는 피부 내 수분 유지 방법은 폐색제(occlusive agent)를 사용하는 것이며, 폐색제는 수분 손실을 막는 장벽을 피부 위에 형성함으로써, 수분 보유를 촉진하는 소수성 물질이다. 가장 일반적으로 사용되는 폐색제에 는, 바세린, 라놀린, 코코아 버터, 미네랄 오일 및 실리콘이 포함된다. 또한, 화장품을 만들기 위해서는 폐색제 이외에도 소듐 라우릴 설페이트(Sodium Lauryl Sulfate), 디메틸 술폭사이드(Dimethyl Sulfoxide), 크로톤 오일(Croton Oil), 수산화나트륨 등과 같이 일반적으로 20 종에서 50 여종의 다양한 원료들이 사용되며, 이들 원료들이 제품에 적용됨으로써 피부에 염증, 가려움증, 알러지 등의 자극을 일으킬 수 있다. 피부가 자극을 일으키는 물질에 노출되면 각질층이 손상을 받게 되고, 각질층 손상의 지표가 되는 경표피 수분손실(Transepidermal Water Loss)이 증가하게 되며, 이는 1차적인 염증반응의 원인이 되기도 한다.Currently, the main method of maintaining water in the skin is to use an occlusive agent, which is a hydrophobic substance that promotes water retention by forming a barrier on the skin that prevents water loss. The most commonly used occlusion agents include petrolatum, lanolin, cocoa butter, mineral oil and silicone. In addition to the occlusion agent, 20 to 50 different raw materials are generally used to make cosmetics, such as sodium lauryl sulfate, dimethyl sulfoxide, croton oil, and sodium hydroxide. As these raw materials are applied to the product, they may cause irritation, itching and allergy to the skin. When the skin is exposed to irritating substances, the stratum corneum is damaged, and transepidermal water loss, which is an indicator of stratum corneum damage, is increased, which may be a primary inflammatory response.
종래의 화장품은 상술한 이유로 인하여 피부에 유해한 부작용이 발생되는 문제점이 있고, 이 때문에 피부 보습 효과, 보호 효과 등을 얻는데 한계가 있다. Conventional cosmetics have a problem that harmful side effects are generated for the skin due to the above-described reasons, and thus there is a limit in obtaining a skin moisturizing effect, a protective effect, and the like.
그러므로, 기존의 보습제가 가지는 부작용 없이 피부 보습량을 증가시키고, 피부 수분증발을 억제하는 물질을 개발하는 데 많은 연구가 진행되고 있다.Therefore, many studies have been conducted to develop a substance that increases skin moisturization and suppresses skin moisture evaporation without side effects of existing moisturizers.
따라서, 본 발명의 목적은 피부 수분량을 증가시키고, 표피의 수분 손실을 억제하며, 독성, 피부알러지, 피부 트러블 등의 부작용을 일으키지 않고, 피부 보습력을 증진시킬 뿐만 아니라 피부의 주름개선에도 효과가 있는 화장료 조성물을 제공하는 데 있다.Accordingly, an object of the present invention is to increase the moisture content of the skin, to suppress the loss of moisture of the epidermis, not to cause side effects such as toxicity, skin allergies, skin problems, etc., as well as to enhance the skin moisturizing power and effective in improving wrinkles of the skin. It is to provide a cosmetic composition.
본 발명자 등은 백리향 추출물이 피부 보습에 효과가 있음을 밝혀내었고, 백 리향 추출물을 화장료 조성물에 제공할 경우에 피부 보습 또는 피부 주름 개선 효과가 우수함을 확인하여 본 발명을 완성하게 되었다.The present inventors have found that the thyme extract is effective in moisturizing the skin, and when the thyme extract is provided to the cosmetic composition, it was confirmed that the skin moisturizing or skin wrinkle improvement effect is excellent, thereby completing the present invention.
본 발명에 따른 백리향 추출물을 함유하는 화장료 조성물은 백리향 추출물이 피부보습력을 상승시킬 뿐만 아니라 표피의 수분증발 억제효과 또한 우수하여 표피의 수분 증발을 현저히 저해하는 효과를 갖고, 피부의 주름개선에도 효과가 있어, 보습 및 주름개선용으로 유용하게 쓰일 수 있다.The cosmetic composition containing the thyme extract according to the present invention not only increases the skin moisturizing power of the thyme extract, but also has an effect of inhibiting the evaporation of the epidermis, which significantly inhibits the evaporation of moisture of the epidermis, and is effective in improving the wrinkles of the skin. It can be useful for moisturizing and wrinkle improvement.
본 발명을 좀 더 상세히 설명하면 다음과 같다.The present invention is described in more detail as follows.
본 발명에 따른 화장료 조성물은 백리향 추출물을 함유하여 피부 보습 증진 및 피부 주름 개선 효과를 갖도록 하는 것을 특징으로 한다.Cosmetic composition according to the invention is characterized in that it contains a thyme extract to have a skin moisturizing and skin wrinkle improvement effect.
백리향(Thymus quinquecostatus)은 꿀풀과의 식물로 한국, 일본, 중국, 몽골, 인도 등의 높은 산꼭대기나 바닷가의 바위틈에 자라며 우리나라가 원산지이다. 높이 3 ∼ 15cm이며, 원줄기는 땅위로 퍼져나가고, 어린 가지가 비스듬히 서며, 향기가 난다. 잎은 마주나고, 긴 타원형이거나 바소꼴이며, 길이 5 ∼ 12mm, 나비 3 ∼ 8mm이다. 양면에 선점(腺點)이 있으며, 가장자리는 밋밋하거나 물결 모양의 톱니가 있고 털이 난다. 꽃은 6월에 분홍색으로 피는데, 잎겨드랑이에 2 ∼ 4개씩 달리며, 지름 7 ∼ 9mm로서 가지 끝부분에 모여나므로 수상꽃차례같이 보인다. 작은 꽃자루는 털이 나며 길이 약 3mm이다. 꽃받침에 10개의 능선이 있다. 화관은 붉은빛을 띤 자주색이고 길이 7 ∼ 8mm로 겉에 잔털과 선점이 있다. 수술은 4개이다. 열매는 작은 견과로서 9월에 짙은 갈색으로 익는다. 줄기가 좀더 굵고 잎 길이 약 15mm, 꽃 길이 약 1cm인 것을 섬백리향(var. japonica)이라고 하는데, 한국 특산종이다. 향기가 있어서 관상용으로 심으며, 포기 전체에 정유(精油)가 있으므로 진해, 진경, 구풍에 사용한다. 한국, 일본, 중국, 몽골, 인도에 분포한다. Thymus quinquecostatus is a plant of the family Lamiaceae and grows in high mountain tops such as Korea, Japan, China, Mongolia, and India or in the crevices of the seashore. Height is 3-15cm, main stem spreads out on the ground, young branches stand at an angle, and smell. The leaves are opposite each other, long oval or lanceolate, 5-12 mm long, and 3-8 mm butterfly. There is a preemption on both sides, the edges are flat or wavy teeth and hairy. Flowers bloom in June in pink, running 2 to 4 on the axilla, 7-9 mm in diameter, gathered at the end of branches, and look like inflorescences. Petioles are hairy, about 3mm long. There are ten ridges on the calyx. Corolla is reddish purple, 7-8mm long, with fine hairs and preoccupation on the outside. There are four surgeries. Fruits are small nuts that ripen in dark brown in September. The stem is thicker, about 15mm long, and about 1cm long, and is called island thyme (var. Japonica). It is planted for ornamental purposes because of its fragrance. It is distributed in Korea, Japan, China, Mongolia, and India.
본 발명에서 백리향 추출물은 물, 탄소수 1 내지 4의 저급 알콜 또는 이들의 혼합 용매로부터 선택된 극성용매를, 가장 바람직하게는, 에탄올을 첨가하여 추출한다.In the present invention, the thyme extract is extracted from water, a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof, most preferably by adding ethanol.
또한, 본 발명에 의한 백리향 추출물은 다음과 같이 제조할 수 있다.In addition, the thyme extract according to the present invention can be prepared as follows.
백리향를 물로 깨끗이 세척한 후, 그늘에서 건조한다. 건조한 백리향을 추출용기에 넣고, 적당량의 추출 용매를 투입하고 적절한 온도에서 일정 시간 추출한다. 상기 추출물은 여과되고, 진공회전증발기 등을 이용하여 농축될 수 있다.Wash thyme with water and dry in the shade. Dry thyme is placed in the extraction container, an appropriate amount of extraction solvent is added and extracted for a certain time at a suitable temperature. The extract can be filtered and concentrated using a vacuum rotary evaporator or the like.
상기 추출 용매로는 물(정제수), 탄소수 1 내지 4의 저급 알콜 또는 이들의 혼합 용매로부터 선택된 극성용매를 사용할 수 있으며, 바람직하게는 에탄올을 사용한다.As the extraction solvent, a polar solvent selected from water (purified water), a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof may be used, and preferably ethanol is used.
상기 추출 용매의 양은 생약 건조 중량의 2 ~ 10 배로 한다.The amount of the extraction solvent is 2 to 10 times the dry weight of the herbal medicine.
상기 추출 온도는 30 ~ 90℃이며, 보다 바람직하게는 60 ~ 80℃이고, 가장 바람직하게는 60℃ 정도로 유지하는 것이 부패, 변색 및 변취의 예방에 가장 효과적이다.The extraction temperature is 30 ~ 90 ℃, more preferably 60 ~ 80 ℃, most preferably maintained at about 60 ℃ is most effective in the prevention of rot, discoloration and odor.
상기 추출 시간은 5 ~ 20 시간이며, 바람직하게는 10 시간이다.The extraction time is 5 to 20 hours, preferably 10 hours.
상기 백리향 추출물을 수득한 후, 거름종이 등을 이용하여 고형분을 제거하 고, 현탁액을 원심분리시키고, 상층액을 감압 여과할 수 있다.After the thyme extract is obtained, the solids may be removed using a filter paper, the suspension may be centrifuged, and the supernatant may be filtered under reduced pressure.
상기 여과된 추출물을 진공회전농축기로 20 ~ 100℃, 바람직하게는 50 ~ 70℃에서 감압농축할 수 있다.The filtered extract can be concentrated under reduced pressure at 20 ~ 100 ℃, preferably 50 ~ 70 ℃ with a vacuum rotary concentrator.
본 발명에서 상기 백리향 추출물은 조성물 총 중량에 대하여 0.005 ~ 50중량% 함유될 수 있다. 상기 백리향 추출물의 함량이 0.005중량% 미만일 경우에는 그 효과를 기대하기 어렵고, 50.0중량% 초과할 경우에는 함량 증가에 따른 뚜렷한 효과의 증가가 나타나지 않는다.In the present invention, the thyme extract may be contained from 0.005 to 50% by weight based on the total weight of the composition. When the content of the thyme extract is less than 0.005% by weight it is difficult to expect the effect, when it exceeds 50.0% by weight does not appear to increase the apparent effect of the increase in content.
본 발명의 조성물은 상기 백리향 추출물에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다.The composition of the present invention may further contain one or more active ingredients exhibiting the same or similar functions in addition to the thyme extract.
본 발명의 백리향 추출물을 유효성분으로 함유하는 화장료 조성물로 제조되는 화장품은 일반적인 유화 제형 및 가용화 제형의 형태로 제조할 수 있다. 유화 제형의 화장품으로는 영양화장수, 크림, 에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 있다. 또한, 본 발명의 백리향 추출물을 함유하는 화장품 이외에도 피부 과학적으로 허용 가능한 매질 또는 기제를 함유함으로써 피부과학 분야에서 통상적으로 사용되는 국소 적용 또는 전신 적용할 수 있는 보조제 형태로 제조될 수 있다.Cosmetics prepared with a cosmetic composition containing the thyme extract of the present invention as an active ingredient can be prepared in the form of a general emulsion formulation and solubilized formulation. Cosmetics of the emulsified formulations include nutrient cosmetics, creams, essences, etc., and cosmetics of the solubilized formulations are flexible cosmetics. In addition to cosmetics containing the thyme extract of the present invention by containing a dermatologically acceptable medium or base may be prepared in the form of adjuvants that can be topically or systemically applied commonly used in the field of dermatology.
적합한 화장품의 제형으로는 예를 들면, 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱(conceal stick)의 형태로 제공 될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.Suitable cosmetic formulations include, for example, emulsions, suspensions, microemulsions, microcapsules, microgranules or ionics (liposomes), nonionics obtained by dispersing an oil phase in a solution, gel, solid or pasty anhydrous product, aqueous phase. It may be provided in the form of a vesicle dispersant, a cream, a skin, a lotion, a powder, an ointment, a spray, or a conceal stick. It may also be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.
또한, 본 발명의 화장료 조성물은 백리향 추출물에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 그리고, 상기의 성분들은 피부과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.In addition, the cosmetic composition of the present invention, in addition to thyme extract, fatty substances, organic solvents, solubilizers, thickening and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water Commonly used in ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics It may contain adjuvants conventionally used in the cosmetic or dermatology field, such as any other ingredient. In addition, the above components may be introduced in an amount generally used in the dermatology field.
본 발명의 화장료 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 수렴화장수, 유연화장수, 영양화장수, 각종 크림, 에센스, 팩, 파운데이션 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.Examples of products to which the cosmetic composition of the present invention may be added include, for example, cosmetics such as astringent cosmetics, soft cosmetics, nourishing cosmetics, various creams, essences, packs, foundations, and the like, cleansing agents, soaps, treatments, and essences. Etc.
본 발명의 화장료 조성물의 구체적인 제형으로서는 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 맛사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 프레스파우더, 루스파우더, 아이섀도 등의 제형을 포함한다.Specific formulations of the cosmetic composition of the present invention include skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, hand cream, essence, nutrition essence, pack, Formulations such as soaps, shampoos, cleansing foams, cleansing lotions, cleansing creams, body lotions, body cleansers, emulsions, press powders, loose powders, eye shadows and the like.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예 및 실험예를 제시한다. 그러나, 하기의 실시예 및 실험예는 본 발명을 보다 쉽게 이해하기 위하여 제 공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred examples and experimental examples are presented to help understand the present invention. However, the following Examples and Experimental Examples are only provided to more easily understand the present invention, and the contents of the present invention are not limited by the Examples.
제조예Production Example 1 : 백리향 추출물의 제조 1: Preparation of Thyme Extract
백리향 50g을 파쇄기에 곱게 파쇄하여 50% 에탄올 200ml에 침지시켜 80℃ 수욕조에서 2시간 이상 온탕하였다. 얻어진 추출액을 실온으로 냉각시키고 거름종이로 여과하여 여과액을 취하였다. 질소를 사용하여 여과액에서 에탄올을 증발시켜 농축한 다음, 이를 10% 에탄올에 녹여 추출물을 제조하였다.50 g of thyme was finely crushed in a crusher and immersed in 200 ml of 50% ethanol and warmed in an 80 ° C. water bath for 2 hours or more. The obtained extract was cooled to room temperature and filtered through a filter paper to give a filtrate. Ethanol was evaporated from the filtrate using nitrogen, concentrated, and then dissolved in 10% ethanol to prepare an extract.
시험예Test Example 1 : 세포보호효과 실험 1: Cytoprotective effect test
제조예 1에서 제조된 백리향 추출물의 자외선으로부터 세포보호 효과를 측정하였다. 섬유아세포를 2*105으로 웰 플레이트에 접종한다. 배지는 일반적으로 사용되는 DMEM 배지를 사용하였으며, 10% FBS에서 24시간 배양하였다. 여기에 백리향 추출물을 처리하고, 2MED의 자외선을 10분간 조사한 후 24시간 동안 배양하였다. 세포생존량은 MTT assay를 이용하여 측정하고, 그 결과를 표 1에 기재하였다.The cytoprotective effect of the thyme extract prepared in Preparation Example 1 was measured. Fibroblasts are seeded in well plates at 2 * 10 5 . As the medium, a commonly used DMEM medium was used and incubated for 24 hours in 10% FBS. The thyme extract was treated here, and irradiated with ultraviolet rays of 2MED for 10 minutes and incubated for 24 hours. Cell viability was measured using MTT assay, the results are shown in Table 1.
제조예Production Example 2 : 2 : 실시예Example 및 And 비교예Comparative example
제조예 1의 백리향 추출물을 함유하는 화장료를 제조하고, 이와 비교하기 위하여 백리향 추출물이 결여된 화장료 조성물을 하기 표 2의 조성비로 제조하였다.A cosmetic composition containing the thyme extract of Preparation Example 1 was prepared, and a cosmetic composition lacking the thyme extract was prepared according to the composition ratio of Table 2 below.
시험예Test Example 2 : 2 : 보습력Moisturizing 개선 임상효과 Improve clinical effect
본 발명의 백리향 추출물을 함유하는 화장료에 대한 피부 보습력 개선 임상효과를 측정하였다. 36세에서 59세의 여성 20명(평균연령 48세)을 대상으로 하였으며, 피부 수분량이 65 이하인 건성 피부를 가진 사람을 선별하였다. 측정하고자 하는 2부위를 정하고 피부의 수분량을 각각 3회에 걸쳐 측정한 후 상기 표 2에 따라 제형하여 4주간 도포(2회/일) 한 후, 피부 수분함량 측정장치인 코네오미터(Corneometer Courage & Khazaka, Germany)를 이용하여 각질층 바로 아래의 표피층의 수분을 측정하고, 그 결과를 표 3에 기재하였다.The clinical effect of improving skin moisturizing power of cosmetics containing thyme extract of the present invention was measured. Twenty females aged 36 to 59 years (mean age 48) were selected and those with dry skin with less than 65 moisture levels were selected. After determining the two parts to be measured and measuring the moisture content of the skin three times each, and formulated according to the above Table 2 and applying for 4 weeks (two times / day), the corneometer (Corneometer Courage) which is a skin moisture content measuring device & Khazaka, Germany) to measure the moisture in the epidermal layer just below the stratum corneum and the results are shown in Table 3.
상기 표 3에 나타난 결과로부터, 실시예의 적용전/후의 상대적인 수치 계산을 통해 살펴보면, 피부 수분도를 측정하는 코네오미터 측정결과 백리향 추출물을 함유하는 실시예 적용 28일 후 수분도가 13% 증가한 것을 확인할 수 있었다. 이러한 효과는 피검자 68%에서 관찰되었다.From the results shown in Table 3 above, when looking through the relative numerical calculation before / after the application of the example, the result of measuring the moisture level of the corneometer measured 28 days after the application of the example containing the thyme extract was confirmed that the moisture content increased by 13% there was. This effect was observed in 68% of the subjects.
결과적으로 상기 표3에 나타난 결과를 통해 확인할 수 있는 사실은 본 발명에 따른 제조예 2에 의해 준비된 백리향 추출물을 함유하는 화장료는 피부 수분도를 증진시키는 것으로서, 피부 보습력에 우수한 효과를 발휘하고 있음을 알 수 있다.As a result, the fact that it can be confirmed through the results shown in Table 3 shows that the cosmetics containing the thyme extract prepared by Preparation Example 2 according to the present invention enhance skin moisture and exert an excellent effect on skin moisturizing power. Can be.
시험예Test Example 3 : 3: 경피Transdermal 수분증발 억제 임상효과 Clinical Effect of Inhibiting Water Evaporation
본 발명의 백리향 추출물을 함유하는 화장료에 대한 경피 수분증발 억제 임상효과를 측정하였다. 36세에서 59세의 여성 20명(평균연령 48세)을 대상으로 하였으며 피부 수분량이 65이하인 건성피부를 가진 사람을 선별하였다. 측정하고자 하는 2부위를 정하고 피부의 수분량을 각각 3회에 걸쳐 측정한 후 상기 표 2에 따라 제형하여 4주간 도포(2회/일) 한 후, 경피 수분증발량 측정장치인 투와미터(Tewameter Courage & Khazaka, Germany)를 이용하여 증발하는 수분의 양을 측정하였다.The clinical effect of inhibiting transdermal moisture evaporation on cosmetics containing the thyme extract of the present invention was measured. Twenty females aged 36 to 59 years (mean age 48) were selected and those with dry skin with less than 65 moisture levels were selected. After determining the two sites to be measured and measuring the moisture content of the skin three times each, and formulated according to the above Table 2 and applying for 4 weeks (two times / day), the Tewameter Courage, a transdermal moisture evaporation measuring device & Khazaka, Germany) to measure the amount of water evaporated.
(적용전)-(적용후)=(△TEWL) (Before)-(after) = (△ TEWL)
상기 표 4에 나타난 결과로부터, 실시예의 경우 경피수분증발 억제가 5.9로 비교예의 2.6보다 2배 이상 높은 것으로 나타났다. From the results shown in Table 4, the inhibition of transdermal moisture evaporation in the case of Example was 5.9, more than twice as high as 2.6 of the comparative example.
결과적으로 상기 표4에 나타난 결과를 통해 확인할 수 있는 사실은 본 발명에 따른 제조예 2에 의해 준비된 백리향 추출물을 함유하는 화장료는 피부 수분손실을 억제시키는 것으로서, 피부 보습력에 우수한 효과를 발휘하고 있음을 알 수 있다.As a result, it can be confirmed through the results shown in Table 4 that the cosmetic composition containing the thyme extract prepared by Preparation Example 2 according to the present invention is to suppress the skin moisture loss, showing an excellent effect on skin moisturizing power Able to know.
시험예Test Example 4 : 외부 주름 개선 임상효과 4: Clinical effect of external wrinkle improvement
본 발명의 백리향 추출물을 함유하는 화장료에 대한 피부 주름 개선 임상효과를 측정하였다. 42세에서 55세의 여성 20명 (평균연령 50세)을 대상으로 하였다. 제조예 2에 따라 제형하여 28일간 도포(2회/일) 한 후, 모사판을 제작하여 S.I.A (silicone image analysis)를 이용하여 분석하고, 그 결과를 표 5 내지 표 7에 기재하였다.The clinical effect of skin wrinkle improvement on cosmetics containing thyme extract of the present invention was measured. Twenty women aged 42 to 55 years (mean age 50) were included. After formulating according to Preparation Example 2 was applied for 28 days (2 times / day), a replica plate was prepared and analyzed using S.I.A (silicone image analysis), and the results are shown in Tables 5 to 7.
상기 표 5 내지 7에 나타난 바와 같이 실시예 적용 28일 후, 총주름 면적과 주름길이가 13% 감소하였고 주름수도 6% 줄어들었으며 총 피검자의 66%에서 주름 부위의 감소가 나타나 피부 주름개선에 효과가 있음을 확인하였다.As shown in Tables 5 to 7, after 28 days of application, the total wrinkle area and the wrinkle length were reduced by 13%, the number of wrinkles was also reduced by 6%, and the wrinkle area was reduced in 66% of the total subjects. It was confirmed that there is.
결과적으로 상기 표5, 6, 7에 나타난 결과를 통해 확인할 수 있는 사실은 본 발명에 따른 추출 실시예에 의해 준비된 생약재 추출물을 함유하는 화장료는 피부주름개선효과를 증진시키는 것으로서, 피부노화방지의 우수한 효과를 발휘하고 있음을 알 수 있다. As a result, the fact that it can be confirmed through the results shown in Tables 5, 6 and 7 is a cosmetic containing the herbal extract prepared by the extraction example according to the present invention to enhance the skin wrinkle improvement effect, excellent skin anti-aging It can be seen that it is effective.
상기 실험예의 결과를 근거로 하여 본 발명의 백리향 추출물을 함유하는 화장료 조성물을 조성하여 제시한다. 그러나, 본 발명의 조성물을 하기의 제형예들로 한정하고자 하는 것은 아니다.Based on the results of the above experimental example, to present a cosmetic composition containing a thyme extract of the present invention. However, the composition of the present invention is not intended to be limited to the following formulation examples.
제형예Formulation example 1 : 유연 화장수 1: flexible lotion
백리향 추출물을 함유한 유연 화장수의 제형예는 다음 표 8의 조성과 같이 제조하였다.Formulation examples of the flexible lotion containing the thyme extract was prepared as shown in Table 8.
제형예Formulation example 2 : 영양 크림 2: nutrition cream
백리향 추출물을 함유한 영양크림의 제형예는 다음 표 9의 조성과 같이 제조하였다. Formulation example of the nutrition cream containing thyme extract was prepared as shown in Table 9.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070092404A KR20090027295A (en) | 2007-09-12 | 2007-09-12 | Cosmetic composition for skin moisturizing containing thyme extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070092404A KR20090027295A (en) | 2007-09-12 | 2007-09-12 | Cosmetic composition for skin moisturizing containing thyme extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090027295A true KR20090027295A (en) | 2009-03-17 |
Family
ID=40694932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070092404A Ceased KR20090027295A (en) | 2007-09-12 | 2007-09-12 | Cosmetic composition for skin moisturizing containing thyme extract |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20090027295A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9468597B1 (en) * | 2013-03-16 | 2016-10-18 | Dr. Perry Skindustries, LLC | Stabilized L-ascorbic acid skin serum |
-
2007
- 2007-09-12 KR KR1020070092404A patent/KR20090027295A/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9468597B1 (en) * | 2013-03-16 | 2016-10-18 | Dr. Perry Skindustries, LLC | Stabilized L-ascorbic acid skin serum |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102280941B1 (en) | Skin moisturizing and skin soothing cosmetic composition comprising Aloe barbadensis leaf juice and extracts of Pulsatilla koreana, Centella asiatica, Portulaca oleracea and Hamamelis virginiana | |
| KR102227355B1 (en) | Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition | |
| KR102015173B1 (en) | Low irritating cosmetic composition for skin whitening | |
| KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
| KR20180083455A (en) | Cosmetic composition comprising dry flower for skin moisture | |
| KR102525579B1 (en) | Composition for protecting skin comprising extract of Oryza Sativa(Rice), Phragmites Communis, Zea Mays(Corn) Silk, Malva Sylvestris(Mallow) and Aloe Barbadensis as active ingredient | |
| KR101020536B1 (en) | Cosmetic composition for moisturizing skin containing cucumber extract and method for producing same | |
| KR100981343B1 (en) | Cosmetic composition for shrinking pores | |
| KR20150086922A (en) | Composition for relieving skin irritation and moisturizing skin containing natural fermented pine leaf extract | |
| KR20190021083A (en) | Cosmetic composition comprising extract of Alpinia officinarum Hance as active ingredient | |
| KR20120009147A (en) | Moisturizing skin external composition containing baekhwasachocho extract | |
| KR20130022476A (en) | A cosmetic composition containing extract of artemisia iwayomogi | |
| KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
| KR101648466B1 (en) | Cosmetic composition for improving skin | |
| KR20110030187A (en) | Cosmetic composition for skin moisturizing containing matsutake mushroom, ghost mushroom, mixed mushroom extract | |
| KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
| KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
| KR100878026B1 (en) | Cosmetic composition for skin moisturizing containing thyme extract stabilized with nanoliposomes | |
| KR102455132B1 (en) | Cosmetic composition containing lemon myrtle extract and its manufacturing method | |
| KR100794518B1 (en) | Cosmetic composition containing pansy extract | |
| KR102541771B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Chaenomeles sinensis fruit, Diospyros kaki leaf, Cinnamomum cassia bark, Artemisia princeps leaf, Chrysanthellum indicum and Camellia sinensis leaf as Active Ingredient | |
| KR20090027295A (en) | Cosmetic composition for skin moisturizing containing thyme extract | |
| KR101825599B1 (en) | Composition of skin external application for moisturizing the skin containing Oldenlandia diffusa extracts | |
| KR102759467B1 (en) | Cosmetic Composition Comprising Stem Cell-Conditioned Media, Centella asiatica Leaf Water and Peptides | |
| KR102202210B1 (en) | Moisturizing cosmetic composition comprising nutmeg extract, hyaluronic acid and sericin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20070912 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20081224 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20090422 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20081224 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |